News
Lisa Freed, MD, FACC, who leads the Women's Heart and Vascular Program at Yale New Haven Hospital discusses how sex and gender differences influence health outcomes.
In response to the COVID-19 pandemic, Lauren Baldassarre, MD, and members of the Cardio-Oncology and Imaging Councils of the American College of Cardiology shared recommendations regarding the cardiovascular care of COVID-19-positive patients.
Rachel Lampert, MD, FACC, was inducted into the Association of University Cardiologists and presented at their annual meeting on Thursday, January 14, 2021.
A simple and free test of your heart health is as close as your nearest high-rise building.
Mahesh Anantha, MD, presented his work as a finalist for the prestigious Jay D. Coffman Early Career Investigator Award for Peripheral Arterial Disease for his work on critical limb ischemia.
This two-part virtual series will be held on Dec. 1 and Dec. 8 at 8:00 a.m. EST via Zoom.
Yale researchers have helped identify the mechanisms behind a major cause of morbidity and mortality in COVID-19 patients.
For the past three years Tayyab Shah, MD, has been involved in the design, implementation, and analysis of multiple clinical trials with Alexandra Lansky, MD.
Yale Cardiovascular Medicine scientists will present research at the American Heart Association’s annual meeting Scientific Sessions 2020 held November 13-17.
Whether it's strange rashes on the toes or blood clots in the brain, the widespread ravages of COVID-19 have increasingly led researchers to focus on how the novel coronavirus sabotages the body's blood vessels.
Industry payments to physicians appear to influence the selection of medical devices used to treat heart rhythm problems, new research suggests.
The standard approach of assessing long-term risk for ASCVD works just as well for patients who are overweight as they do for patients at an optimal weight, according to a new study in JAMA Network Open.
A new study led by a Yale physician analyzes the variations in how often heart failure occurs in patients with risk factors such as hypertension, diabetes, obesity, atrial fibrillation, and a previous heart attack.
On Oct. 22, Yale New Haven Health’s atrial fibrillation program became the first institution in Connecticut to successfully implant a new, left atrial appendage (LAA) closure device that doctors said results in fewer procedural complications and a faster recovery period.
Kim Smolderen, PhD, Co-Director of the Vascular Medicine OutcomeS (VAMOS) research program, has been awarded a research grant to conduct a prospective observational study on patients with Critical Limb Ischemia.
Transcatheter aortic valve replacement (TAVR) procedures appear to be safe for low-risk patients with bicuspid aortic valve disease, according to a new study published in JAMA Cardiology.
Lynda Rosenfeld, MD, has witnessed remarkable changes over her career as a physician and mentor.
Doctors at Yale New Haven Hospital used a more aggressive selection process to more than quadruple the number of heart transplants performed there while maintaining positive patient outcomes, according to a new study.
Led by researchers at Yale, emerging evidence published last month in JACC: Cardiovascular Interventions evaluates the safety and efficacy of TAVR in patients with bicuspid aortic valve stenosis.
Emerging information from cardiac electrophysiologists at Yale New Haven Hospital’s (YNHH) Heart and Vascular Center shows that hospital safety protocols were effective at preventing the spread of COVID-19.
